Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
U6 small nuclear RNA 85, pseudogene (RNU6-85P), is a genomic sequence in humans derived from the U6 small nuclear RNA gene but has lost its original snRNA function due to mutations and is classified as a noncoding RNA pseudogene. The canonical U6 snRNA is a key component of the spliceosome, the complex that catalyzes removal of introns from pre-mRNA during splicing, and is highly conserved across species, reflecting its essential role in gene expression. Numerous U6 snRNA pseudogenes, including RNU6-85P, are present throughout the human genome, and their proliferation is linked to retrotransposition events, particularly those mediated by LINE-1 elements. These pseudogenes serve as markers of retrotransposition activity but are not transcribed into functional snRNA, nor do they encode proteins. There is no evidence that RNU6-85P is functionally active, pathogenic, or relevant as a therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on U6 small nuclear RNA 85, pseudogene (RNU6-85P).